Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4765384 | 0.95 | MAPT (0.50) | MAPTALDH1A1MAPK14GAAMAPK1 | |
| Trifluoroacetic Acid SCHEMBL4767843 | 0.88 | MAPT (0.46) | MAPTALDH1A1MAPK14GAAMAPK1 | |
| SCHEMBL4765178 | 0.88 | ALDH1A1 (0.58) | MAPTALDH1A1MAPK14GAAMAPK1 | |
| Hydrochloric Acid SCHEMBL4765416 | 0.88 | ALDH1A1 (0.57) | MAPTALDH1A1MAPK14GAAMAPK1 | |
| Trifluoroacetic Acid SCHEMBL4765179 | 0.87 | SLC2A1 (0.44) | MAPTALDH1A1HRH3SLC2A1SMN1; SMN2 | |
| SCHEMBL4771068 | 0.84 | NR1H4 (0.43) | MAPTALDH1A1HRH3SMN1; SMN2TP53 | |
| SCHEMBL4765305 | 0.83 | RAB9A (0.48) | POLBHRH3SMN1; SMN2 | |
| SCHEMBL4770698 | 0.82 | MAPT (0.45) | MAPTALDH1A1GAAMAPK1HRH3 | |
| Hydrochloric Acid SCHEMBL4774495 | 0.82 | RAB9A (0.47) | POLBHRH3SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL4771045 | 0.81 | RAB9A (0.53) | POLBSLC2A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | claimed |
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | GLAXO GROUP LIMITED (GB) | 2007-03-15 | — | — | US | claimed |
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | HRH3, HRH4, HRH1 | MAPT 405/4885ALDH1A1 1725/4885MAPK14 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.